Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Enveric Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −15 vs. Q2 2022
- Shares held
- 147.6K
- −38.6K (−20.7%) vs. Q2 2022Converted for a 1-for-50 split
- Total value
- $623.0K
- −$1.37M (−68.8%) vs. Q2 2022
- New holders
- 1
- 7 more added
- Sold out
- 16
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $736.8K |
| Q1 2026 | 11 | $106.6K |
| Q4 2025 | 11 | $87.7K |
| Q3 2025 | 11 | $232.6K |
| Q2 2025 | 14 | $283.2K |
| Q1 2025 | 15 | $344.7K |
| Q4 2024 | 19 | $386.7K |
| Q3 2024 | 17 | $337.2K |
| Q2 2024 | 17 | $307.3K |
| Q1 2024 | 18 | $488.4K |
| Q4 2023 | 15 | $635.8K |
| Q3 2023 | 15 | $518.3K |
| Q2 2023 | 14 | $631.1K |
| Q1 2023 | 13 | $382.4K |
| Q4 2022 | 12 | $356.8K |
| Q3 2022 | 12 | $623.0K |
| Q2 2022 | 27 | $1.99M |
| Q1 2022 | 31 | $3.61M |
| Q4 2021 | 31 | $4.45M |
| Q3 2021 | 24 | $4.64M |
| Q2 2021 | 18 | $2.72M |
| Q1 2021 | 14 | $3.42M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Enveric Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 78,354 | $331.0K | 0.09% | +53,306+212.8% | AddedConverted for a 1-for-50 split |
| BlackRock Inc. | 29,578 | $125.0K | 0.00% | +20,568+228.3% | AddedConverted for a 1-for-50 split |
| Vanguard Group Inc | 14,425 | $61.0K | 0.00% | −787−5.2% | ReducedConverted for a 1-for-50 split |
| Hudson Bay Capital Management LP | 10,906 | $46.0K | 0.00% | −80,592−88.1% | ReducedConverted for a 1-for-50 split |
| Tower Research Capital LLC (TRC) | 7,660 | $32.0K | 0.00% | +6,838+832.2% | AddedConverted for a 1-for-50 split |
| UBS Group AG | 5,202 | $22.0K | 0.00% | +5,192+54,428.3% | AddedConverted for a 1-for-50 split |
| Group One Trading, L.P. | 1,185 | $5.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Royal Bank of Canada | 181 | $1.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Wells Fargo & Company | 27 | $0 | 0.00% | +5+20.5% | AddedConverted for a 1-for-50 split |
| FMR LLC | 1 | $0 | 0.00% | +1+1,566.7% | AddedConverted for a 1-for-50 split |
| Morgan Stanley | 2 | $0 | 0.00% | +2+9,900.0% | AddedConverted for a 1-for-50 split |
| Bank of America Corp | 100 | $0 | 0.00% | +100 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −21,842−100.0% | Sold outConverted for a 1-for-50 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −4,552−100.0% | Sold outConverted for a 1-for-50 split |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −4,477−100.0% | Sold outConverted for a 1-for-50 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −4,091−100.0% | Sold outConverted for a 1-for-50 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −3,331−100.0% | Sold outConverted for a 1-for-50 split |
| State Street Corp | 0 | $0 | 0.00% | −1,813−100.0% | Sold outConverted for a 1-for-50 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −730−100.0% | Sold outConverted for a 1-for-50 split |
| Scotia Capital Inc. | 0 | $0 | 0.00% | −532−100.0% | Sold outConverted for a 1-for-50 split |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −516−100.0% | Sold outConverted for a 1-for-50 split |
| Veritable, L.P. | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-50 split |
| Creative Planning | 0 | $0 | 0.00% | −352−100.0% | Sold outConverted for a 1-for-50 split |
| HRT Financial LP | 0 | $0 | 0.00% | −274−100.0% | Sold outConverted for a 1-for-50 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −208−100.0% | Sold outConverted for a 1-for-50 split |
| Cutler Group LP | 0 | $0 | 0.00% | −112−100.0% | Sold outConverted for a 1-for-50 split |
| Credit Suisse AG | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-50 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold outConverted for a 1-for-50 split |